News - Media

Dr. Sayuri Suzuki and colleagues show that the cannabinoid CBGA potently inhibits the TRPM7 channel. The manuscript has been published in the journal Function.

Dr. Suzuki’s study demonstrates that CBGA potently inhibits TRPM7 currents. Dr. Suzuki previously reported that CBGA has a potent inhibitory effect on both Store-Operated Calcium Entry (SOCE) via inhibition Calcium Release-Activated Calcium (CRAC) channels as well as the channel-kinase TRPM7.  In this study, the authors comprehensively

Read More »

Congratulations to Dr. Michael A. Ortega for being awarded an R21 grant through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH)! Dr. Ortega’s lab is based out of the Queen’s Medical Center for Biomedical Research (QCBR), where his team investigates mechanisms of kidney injury response.

The grant titled “TWEAK-Fn14 regulation of non-canonical NF-κB signaling in chronic renal inflammation,” will support the Ortega Lab for 3 years as the team focuses

Read More »